Ci Private Wealth, LLC Fate Therapeutics Inc Transaction History
Ci Private Wealth, LLC
- $63.6 Billion
- Q1 2024
A detailed history of Ci Private Wealth, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Ci Private Wealth, LLC holds 37,503 shares of FATE stock, worth $160,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,503
Previous 29,649
26.49%
Holding current value
$160,137
Previous $110,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FATE
# of Institutions
178Shares Held
124MCall Options Held
222KPut Options Held
48.6K-
Redmile Group, LLC San Francisco, CA13.2MShares$56.2 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.91MShares$42.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$38.9 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$35.1 Million3.14% of portfolio
-
State Street Corp Boston, MA8.04MShares$34.3 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $414M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...